⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LGVNR News
Longeveron® Granted Japan Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
globenewswire.com
LGVNR
LGVN
Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
globenewswire.com
LGVN
LGVNR